Of relevance, we found pathways related to immunomodulation were enriched in both ARK1 and Ishikawa GZD824‐treated cells, suggesting another potential anti‐tumour activity mechanism for GZD824 in EC. The gene discussed is AURKA; the disease is neoplasm.